Disparities in Cancer Care | Specialty

The OncLive Disparities in Cancer Care condition center page is a comprehensive resource for clinical news and expert insights on disparities in care with regards to race, gender, demographics, geographics, and socioeconomic status. This page features news articles, interviews in written and video format, and podcasts that focus on studies evaluating these various disparities and how they impact clinical trial enrollment and oncology treatment.

Study Highlights Racial, Ethnic Disparities in Post-Breast Cancer Surgery Emergency Department Visits

October 19th 2021

Non-Hispanic Black women are approximately 40% more like to require a visit to the emergency department after breast cancer surgery, and Hispanic women are 11% more likely compared with non-Hispanic White women, according to results from a population-based study published in Breast Cancer Research and Treatment.

Now Is the Time to Improve Diversity in Cancer Clinical Trials

September 27th 2021

Participating in a clinical trial is the most effective way to gain access to new and potentially better ways to treat cancer, yet we’ve seen a decrease in the number of African American and Hispanic patients participating in oncology trials in 2003 to 2016, compared with 1996 to 2002.

Racial, Social Disparities Linked With T-Cell Lymphoma Outcomes

September 11th 2021

Existing racial and socioeconomic disparities among patients with T-cell non-Hodgkin lymphoma continue to lead to obstacles with access for newly available treatment options.

Dr. Chu on Ongoing Efforts to Address Disparities in Lung Cancer

August 26th 2021

Edward Chu, MD, MMS, discusses ongoing efforts to address disparities in lung cancer at Montefiore and Albert Einstein College of Medicine.

Cancer Screenings Recover From Height of COVID-19 Pandemic, But Disparities Remain

August 19th 2021

Chris Labaki, MD, and Quoc-Dien Trinh, MD, discuss their research on the decline in cancer screenings during the height of the COVID-19 pandemic, the recovery of these tests, and potential existing disparities to be addressed.

Smarter Screening, Risk Assessments Are Key to Eliminating Racial Disparities in Breast Cancer Outcomes

August 9th 2021

“Smarter screening” and a better understanding of the breast cancers women of color are more likely to develop are all crucial to helping these patients survive this disease at the same rates as their White counterparts.

Dr. Malhotra on the Rationale to Evaluate Racial Disparities in Lung Cancer Survivors

August 5th 2021

Jyoti Malhotra, MD, MPH, discusses the rationale to evaluate racial disparities in lung cancer survivors.

Understanding Actionable Pathogenic Variants Among Caribbean Patients With Breast and Ovarian Cancers

July 29th 2021

Dr. George and Dr. Hurley discuss the data generated from their study on the correlation between deleterious variants in genes and the development of hereditary breast and ovarian cancers in populations throughout the Caribbean.

Disparities in Race and Socioeconomic Factors Linked With Outcomes in LS-SCLC

July 27th 2021

Racial minorities with limited-stage small cell lung cancer, including African American and Asian patients, were found to have more favorable survival outcomes compared with White patients, which suggests that race is associated with survival in this disease.

Examining Interventions to Increase Participation of Hispanic/Latinx Populations to Clinical Trials for Cancers

July 23rd 2021

Rodolfo Gutierrez, MD, discusses racial disparities in cancer care and interventions to encourage increased participation of the Hispanic and Latinx community on clinical trials.

Understanding Etiology of TNBC is Critical for Discovering Effective Preventive Approaches

July 22nd 2021

Mark E. Sherman, MD, discusses research efforts evaluating immune responses and risk of TNBC and implications for higher rates of disease among African American women.

Dr. Pederson on the Importance of Ancestrally-Unbiased Polygenic Risk Assessment in Breast Cancer

June 24th 2021

Holly Pederson, MD, discusses the importance of ancestrally-unbiased polygenic risk assessment in patients with breast cancer.

Dr. Nguyen on Enrollment Disparities in Pivotal Clinical Trials in Oncology

June 23rd 2021

Ryan Nguyen, DO, discusses enrollment disparities in pivotal clinical trials in oncology.

Multiple Factors Contribute to Disparities in Health and Cancer Outcomes

June 18th 2021

The issue of disparities in cancer is multifactorial, as it can cover not only race, ethnic, and cultural issues, but also gender identification.

Dr. Blanter on Racial Disparities in Development of Distant Metastases in Breast Cancer

June 18th 2021

Julia Blanter, MD, discusses the risk of developing distant metastases after initial breast cancer diagnosis among Black vs White women.

Dr. Hoskins on the Impact of Race on Breast Cancer Outcomes

June 16th 2021

Kent Hoskins, MD, discusses the impact of race on breast cancer outcomes.